srt-3025 srt-3025 srt-3025 is an experimental drug that was studied by sirtris pharmaceuticals as a small-molecule activator of the sirtuin subtype sirt1. it has been investigated as a potential treatment for osteoporosis, and anemia. srt-3025identifiers iupac name 5-(3-methoxypropyl)-2-phenyl-n-thiazolopyridin-2-yl]phenyl]-1,3-thiazole-4-carboxamide cas number1231952-55-8 ypubchem cid46245047uniil4wq6846srchemical and physical dataformulac31h31n5o2s2molar mass569.74 g·mol−13d model (jsmol)interactive image smiles cocccc1=c(n=c(s1)c2=cc=cc=c2)c(=o)nc3=cc=cc=c3c4=nc5=c(s4)n=cc(=c5)cn6cccc6 inchi inchi=1s/c31h31n5o2s2/c1-38-17-9-14-26-27(35-29(39-26)22-10-3-2-4-11-22)28(37)33-24-13-6-5-12-23(24)30-34-25-18-21(19-32-31(25)40-30)20-36-15-7-8-16-36/h2-6,10-13,18-19h,7-9,14-17,20h2,1h3,(h,33,37)key:mrrxpmznbrxcpz-uhfffaoysa-n